10
M. Al-Azani et al. / C. R. Chimie xxx (2016) 1e12
(Cquat), 130.9 (CH),131.3 (CH), 132.3 (CH), 133.6 (Cquat), 165.9
(Cquat, CO).
55.3 (OCH3), 104.0 (CH), 114.7 (2C, CH), 127.3 (2C, CH), 128.7
(Cquat), 136.5 (CH), 159.6 (Cquat) and 13e (826 mg, 80%) as a
pale yellow solid; mp 130e133 ꢀC; IR (KBr) nmax: 1754,1624,
1602, 1573, 1524, 1513, 1351, 1309, 1286, 1249, 1178, 1102,
4.4.5. 3-O-Methylestra-1,3,5(10)-trien-17b-yl 4-(E)-
methoxycinnamate (11e)
1026, 981, 921, 825, 735 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d:
As a colorless solid, mp 126e128 ꢀC; IR (KBr/cmꢁ1
)
nmax
:
2.50 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.46 (d, 3J ¼ 16.0 Hz,
2919, 2866, 2836, 1701, 1636, 1604, 1575, 1512, 1497, 1323,
1H), 6.92 (d, 3J ¼ 8.8 Hz, 2H), 7.53 (d, 3J ¼ 8.8 Hz, 2H), 7.60
1257, 1205, 1172, 1033, 984, 967, 828, 812; 1H NMR
(dd, J ¼ 8.0 Hz, 3J ¼ 8.0 Hz, 1H), 7.82 (d, 3J ¼ 16.0 Hz, 1H),
3
(400 MHz, CDCl3)
d: 0.90 (3H, s, CH3), 1.25e2.31 (13H, m),
8.20 (dm, 3J ¼ 8.0 Hz, 1H), 8.29 (dm, 3J ¼ 8.0 Hz, 1H), 8.56
2.85e2.87 (2H, m), 3.77 (3H, s, OCH3), 3.83 (3H, s, OCH3),
4.82 (1H, dd, 3J ¼ 9.2 Hz, 3J ¼ 8.0 Hz), 6.32 (1H, d,
3J ¼ 16.0 Hz), 6.63 (1H, d, 4J ¼ 2.8 Hz), 6.70 (1H, dd,
3J ¼ 8.8 Hz, 4J ¼ 2.8 Hz), 6.90 (2H, d, 3J ¼ 8.8 Hz), 7.20 (1H, d,
3J ¼ 8.4 Hz), 7.48 (2H, d, 3J ¼ 8.8 Hz), 7.62 (1H, d,
(dd, 4J ¼ 2.0 Hz, 4J ¼ 1.6 Hz, 1H); 13C NMR (100.5 MHz,
CDCl3) d: 14.4 (CH3), 55.4 (OCH3), 112.4 (CH), 114.4 (2C, CH),
122.1 (CH), 125.1 (CH), 126.9 (Cquat), 129.7 (CH), 130.1 (2C,
CH), 132.9 (CH), 136.8 (Cquat), 146.5 (CH), 148.4 (Cquat), 160.5
(Cquat), 161.8 (Cquat), 164.6 (Cquat). Anal. Calcd for
C18H16N2O5 (340.33): C, 63.63; H, 4.85; N, 8.19%. Found: C,
63.89; H, 4.87; N, 7.96%.
3J ¼ 16.0 Hz); 13C NMR (100.5 MHz, CDCl3)
d
: 12.2, 23.3,
26.2, 27.2, 27.7, 29.8, 37.0, 38.6, 43.2, 43.8, 49.8, 55.2 (OCH3),
55.4 (OCH3), 82.6 (OCH), 111.5 (CH), 113.8 (CH), 114.3 (2C,
CH), 116.1 (CH), 126.4 (CH), 127.2 (Cquat), 129.7 (2C, CH),
132.5 (Cquat), 137.9 (Cquat), 144.0 (CH), 157.4 (Cquat), 161.3
(Cquat), 167.4 (Cquat, CO). Anal. Calcd for C29H34O4. (446.58):
C, 78.00%; H, 7.67%. Found: C, 78.14%; H, 7.44%.
4.5.2. 3-O-Methyl estra-1-3,5(10)-trien-17-one-17-oxime N-
3,4-(E)-dimethoxycinnamate (13a)
As a colorless solid, mp 152e154 ꢀC (isopropanol/diethyl
ether); IR (KBr/cmꢁ1
) nmax 3061, 2930, 2864, 2837, 1734,
1627, 1597, 1513, 1465, 1420, 1307, 1266, 1236, 1162, 1124,
4.4.6. 3-O-Methylestra-1,3,5(10)-trien-17b-yl 3,4-(E)-
1021, 979, 863, 816 cmꢁ1; 1H NMR (CDCl3, 400 MHz, CDCl3)
dimethoxycinnamate (11f)
d
: 0.83e2.91 (m, 15H), 1.05 (s, 3H, CH3), 2.91 (s, 3H, OCH3),
As a colorless solid, mp 162e165 ꢀC; nmax (KBr/cmꢁ1
)
3.77 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 6.37 (d, 3J ¼ 16.0 Hz,
1H), 6.63 (d, 4J ¼ 2.8 Hz, 1H), 6.71 (dd, 3J ¼ 8.8 Hz,
4J ¼ 2.8 Hz,1H), 6.87 (d, 3J ¼ 8.4 Hz,1H), 7.06 (d, 4J ¼ 2.0 Hz),
7.13 (dd, 3J ¼ 8.4 Hz, 4J ¼ 2.0 Hz,1H), 7.21 (d, 3J ¼ 8.8 Hz,1H),
3010, 2953, 2863, 2843, 2805, 2698, 1612, 1596, 1510, 1445,
1417, 1294, 1257, 1155, 1139, 1024, 848, 812, 782, 616, 570;
dH (400 MHz, CDCl3) 0.90 (3H, s, CH3), 2.84e2.88 (2H, m),
1.25e2.31 (13H, m), 3.77 (3H, s, OCH3), 3.91 (3H, s, OCH3),
3.92 (3H, s, OCH3), 4.83 (1H, dd, 3J ¼ 8.0, 3J ¼ 7.6 Hz, OCH),
6.32 (1H, d, 3J ¼ 16.0 Hz), 6.63 (1H, d, 4J ¼ 2.8 Hz), 6.70
(1H, dd, 3J ¼ 8.4 Hz, 4J ¼ 2.8 Hz), 6.86 (1H, d, 3J ¼ 8.4 Hz),
7.05 (1H, d, 4J ¼ 2.0 Hz), 7.10 (1H, dd, 3J ¼ 8.4 Hz,
4J ¼ 2.0 Hz), 7.20 (1H, d, 3J ¼ 8.4 Hz), 7.61 (1H, d,
3J ¼ 16.0 Hz); dC (100.5 MHz, CDCl3) 12.2, 23.3, 26.2, 27.2,
27.7, 29.8, 37.0, 38.6, 43.2, 43.8, 49.8, 55.2 (OCH3), 55.9
(OCH3), 56.0 (OCH3), 82.7 (OCH), 109.5, 111.0, 111.5, 113.8,
116.2, 122.6, 126.4, 127.5, 132.5, 137.9, 144.3, 149.2 (Cquat),
151.0 (Cquat), 157.4 (Cquat), 167.3 (Cquat, CO). Found: C,
75.76%; H, 7.32%. Calcd. for C30H36O5. (476.60): C, 75.60%;
H, 7.61%.
7.71 (d, 3J ¼ 16.0 Hz, 1H); 13C NMR (CDCl3, 100.5 MHz)
d:
17.1, 22.9, 26.1, 27.2, 27.3, 29.6, 33.7, 38.2, 43.8, 45.5, 52.8,
55.2 (OCH3), 55.9 (OCH3), 56.0 (OCH3), 109.7, 111.0, 111.5,
113.8, 113.9, 122.7, 126.4, 127.4, 132.1, 137.6, 145.4, 149.2,
151.2, 157.5, 165.1, 178.7 (Cquat, CO). Found: C, 73.69%; H,
7.37%; N, 2.73%. Calcd. for C30H35NO5 (489.60): C, 73.59%; H,
7.21%; N, 2.86%.
4.5.3. Fluoren-9-one oxime benzoate (13b)
As a yellow solid, mp 180e183 ꢀC; IR (KBr) nmax: 1743,
1597, 1449, 1319, 1248, 1178, 1091, 1081, 1064, 1026, 975,
889, 785, 731, 711, 644 cmꢁ1; 1H NMR (CDCl3, 400 MHz)
d:
7.30e7.69 (m, 9H), 8.01 (d, 3J ¼ 7.6 Hz, 1H), 8.21 (d,
3J ¼ 7.2 Hz, 2H), 8.29 (d, 3J ¼ 7.6 Hz, 1H); 13C NMR (CDCl3,
4.5. General procedure for the preparation of O-acyloximes
100.5 MHz) d: 120.1 (CH), 120.4 (CH), 123.6 (CH),128.5 (CH),
128.6 (CH), 128.8 (2C, CH), 128.9 (Cquat), 129.9 (3C, CH),
130.1 (Cquat), 131.7 (CH), 132.6 (CH), 133.6 (CH), 134.5 (Cquat),
141.1 (Cquat), 142.8 (Cquat), 159.1 (Cquat), 164.2 (Cquat). Anal.
Calcd for C20H13NO2. (299.32) 0.2H2O: C, 79.30%; H, 4.46%,
N 4.62%. Found: C, 79.26%; H, 4.34%; N, 4.64%.
4.5.1. 3-Nitroacetophenone oxime 4-methoxycinnamate (13e)
To
a
solution of triphenylphosphine (910 mg,
3.47 mmol) in dry dichloromethane (10 mL) bromotri-
chloromethane (710 mg, 3.58 mmol) was added, and the
resulting mixture was stirred at a rate for 30 min to give a
reddish-brownish solution. Then, 4-methoxycinnamic acid
(4d, 542 mg, 3.04 mmol) was added, and the mixture was
stirred at reflux for 45 min. Thereafter, 3-
nitroacetophenone oxime (12c, 545 mg, 3.03 mmol) was
added, and the mixture was stirred at reflux for another
12 h. Column chromatography on a silica gel (CH2Cl2) gave
(E)-1-bromo-2-(4-methoxyphenyl)ethene (6, 77 mg, 12%)
[41] as a colorless solid; mp 52e56 ꢀC (Lit. mp 58e59 ꢀC
[42]); nmax (KBr/cmꢁ1) 2958, 2837, 1607, 1512, 1256, 1028,
950, 927, 836, 777, 526; dH (400 MHz, CDCl3) 6.60 (1H, d,
3J ¼ 14.0 Hz), 6.84 (2H, d, 3J ¼ 8.4 Hz), 7.03 (1H, d,
3J ¼ 14.0 Hz), 7.22 (2H, d, 3J ¼ 8.4 Hz); dC (100.5 MHz, CDCl3)
4.5.4. Fluoren-9-one oxime cinnamate (13c)
As a pale yellow solid; mp 126e128 ꢀC; IR (KBr) nmax
:
3029, 1746, 1634, 1449, 1308, 1116, 951, 788, 761, 733,
646 cmꢁ1; 1H NMR (CDCl3, 400 MHz)
d
: 6.74 (d, 3J ¼ 16.0 Hz,
1H), 7.28e7.66 (m, 11H), 7.97 (md, 1H), 7.98 (d, 3J ¼ 16.0 Hz,
1H), 8.31 (md, 1H); 13C NMR (CDCl3, 100.5 MHz)
d: 114.9
(CH), 120.1 (CH), 120.3 (CH), 123.5 (CH), 128.4 (3C, CH),
128.5 (CH), 129.0 (2C, CH), 130.1 (CH), 130.2 (Cquat), 130.9
(CH), 131.7 (CH), 132.6 (CH), 134.1 (Cquat), 134.5 (Cquat), 141.2
(Cquat), 142.6 (Cquat), 147.3 (CH), 158.4 (Cquat), 164.6 (Cquat
,
CO). Anal. Calcd for C22H15NO2 (325.36): C, 81.21%; H,
4.65%; N, 4.30%. Found: C, 81.49%; H, 4.70%; N, 4.36%.
Please cite this article in press as: M. Al-Azani, et al., The use of BrCCl3-PPh3 in Appel type transformations to esters, O-acy-